breast cancer

Neoadjuvant therapy is of great significance for the comprehensive treatment of HER2-positive breast cancer. With the updating and improvement of anti-HER2 treatment concepts, more and more HER2-targeted therapeutic drugs are approved and gradually move towards clinical application.

Breast cancer, one of the most prevalent malignant tumors among women, poses a significant threat to their health. Surgery is an essential localized treatment for these patients, and dealing with axillary lymph nodes, breast conservation, and reconstruction are crucial components in transitioning to individualized treatment.